mgs-0039 mgs-0039 mgs-0039 is a drug that is used in neuroscientific research, which acts as a potent and selective antagonist for group ii of the metabotropic glutamate receptors (mglur2/3). it produces antidepressant and anxiolytic effects in animal studies, and has been shown to boost release of dopamine and serotonin in specific brain areas. research has suggested this may occur through a similar mechanism as that suggested for the similarly glutamatergic drug ketamine. mgs-0039clinical dataatc codenonelegal statuslegal status in general: non-regulated identifiers iupac name (1r,2r,3r,5r,6r)-2-amino-3-(3,4-dichlorobenzyloxy)-6-fluorobicyclohexane-2,6-dicarboxylic acid cas number569686-87-9pubchem cid9886034iuphar/bps1397chemspider8061707uniim8kc1pq31acomptox dashboard (epa)dtxsid40432407 chemical and physical dataformulac15h14cl2no5molar mass359.18 g·mol−13d model (jsmol)interactive image smiles f2(c(=o)o)3(c(=o)o)(n)(occ1ccc(cl)c(cl)c1)c23 inchi inchi=1s/c15h14cl2fno5/c16-8-2-1-6(3-9(8)17)5-24-10-4-7-11(14(7,18)12(20)21)15(10,19)13(22)23/h1-3,7,10-11h,4-5,19h2,(h,20,21)(h,22,23)/t7-,10-,11+,14-,15+/m1/s1key:lfaggdazzkuvko-jagwwqspsa-n